Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CAT-2003: Preliminary Phase I data

Preliminary data from a 2-part, double-blind, placebo-controlled, U.S. Phase I trial showed that oral CAT-2003 was

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE